IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 8280-8286

  Yoo, Jae Kwang ^a   Kwon, Hyokjoon ^a   Khil, Lee Young ^a   Zhang, Li ^b   Jun, Hee Sook ^a,c,d,e   Yoon, Ji Won ^a,c,e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c The Chicago Medical College   (United States)

^d Chosun University   (South Korea)

^e ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 29144473003     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.8280     Document Type: Article

References (42)

1. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
2. LeBlanc, P. A., L. S. Heath, and H. D. Um. 1990. Activated macrophages use different cytolytic mechanisms to lyse a virally infected or a tumor target. J. Leukocyte Biol. 48: 1-6.
3. Hartung, H. P., S. Jung, G. Stoll, J. Zielasek, B. Schmidt, J. J. Archelos, and K. V. Toyka. 1992. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40: 197-210.
4. Yoon, J. W., and H. S. Jun. 2002. Macrophages in autoimmunity and primary immunodeficiency. In The Macrophage. B. Burke, and C. Lewis, eds. Oxford University Press, London, p. 257-290.
5. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378: 88-91.
6. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H, Okamura. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19: 423-474.
7. Dinarello, C. A. 1999. Interleukin-18. Methods 19: 121-132.
8. + human blood mononuclear cells. J. Clin. Invest. 101: 711-721.
9. Muhl, H., and J. Pfeilschifter. 2004. Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur. J. Pharmacol. 500: 63-71.
10. Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27: 4162-4168.
11. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91: 3652-3656.
12. 2+ mobilization, and enzyme release. J. Immunol. 156: 322-327.
13. Kuna, P., S. R. Reddigari, D. Rucinski, J. J. Oppenheim, and A. P. Kaplan. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J. Exp. Med. 175: 489-493.
14. Daly, C., and B. J. Rollins. 2003. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10: 247-257.
15. Jee, Y., W. K. Yoon, Y. Okura, N. Tanuma, and Y. Matsumoto. 2002. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 128: 49-57.
16. Koch, A. E., S. L. Kunkel, L. A. Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1992, Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90: 772-779.
17. Chung, Y. H., H. S. Jun, Y. Kang, K. Hirasawa, B. R. Lee, N. Van Rooijen, and J. W. Yoon. 1997. Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J. Immunol. 159: 466-471.
18. Hirasawa, K., H. S. Jun, H. S. Han, M. L. Zhang, M. D. Hollenberg, and J. W. Yoon. 1999. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages. J. Virol. 73: 8541-8548.
19. Mendez, I. I., Y. H. Chung, H. S. Jun, and J. W. Yoon. 2004. Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J. Immunol. 173: 1327-1335.
20. Munder, M., M. Mallo, K. Eichmann, and M. Modolell. 1998. Murine macrophages secrete interferon-γ upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187: 2103-2108.
21. Kanakaraj, P., K. Ngo, Y. Wu, A. Angulo, P. Ghazal, C. A. Harris, J. J. Siekierka, P. A. Peterson, and W. P. Fung-Leung. 1999. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 189: 1129-1138.
22. Ferrero, E., P. Biswas, K. Vettoretto, M. Ferrarini, M. Uguccioni, L. Piali, B. E. Leone, B. Moser, C. Rugarli, and R. Pardi. 2003. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on γδ cells. Immunology 108: 365-374.
23. Jun, H. S., C. S. Yoon, L. Zbytnuik, N. van Rooijen, and J. W. Yoon. 1999. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 189: 347-358.
24. Baek, K. H., S. J. Ha, and Y. C. Sung. 2001. A novel function of phosphorothioate oligodeoxynucleotides as chemoattractants for primary macrophages. J. Immunol. 167: 2847-2854.
25. + T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J. Immunol. 169: 3637-3643.
26. Hirasawa, K., A. Kim, H. S. Han, J. Han, H. S. Jun, and J. W. Yoon. 2003. Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus. J. Virol. 77: 5649-5656.
27. Kwon, H., H. S. Jun, L. Y. Khil, and J. W. Yoon. 2004. Role of CTLA-4 in the activation of single- and double-positive thymocytes. J. Immunol. 173: 6645-6653.
28. Zhou, Z. H., P. Chaturvedi, Y. L. Han, S. Aras, Y. S. Li, P. E. Kolattukudy, D. Ping, J. M. Boss, and R. M. Ransohoff. 1998. IFN-γ induction of the human monocyte chemoattractant protein (hMCP)-1 gene in astrocytoma cells: functional interaction between an IFN-γ-activated site and a GC-rich element. J. Immunol. 160: 3908-3916.
29. Bosco, M. C., M. Puppo, S. Pastorino, Z. Mi, G. Melillo, S. Massazza, A. Rapisarda, and L. Varesio. 2004. Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J. Immunol. 172: 1681-1690.
30. Feng, G. J., H. S. Goodridge, M. M. Harriett, X. Q. Wei, A. V. Nikolaev, A. P. Higson, and F. Y. Liew. 1999. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163: 6403-6412.
31. Morel, J. C., C. C. Park, J. M. Woods, and A. E. Koch. 2001. A novel role for interleukin-18 in adhesion molecule induction through NF-κB and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J. Biol. Chem. 276: 37069-37075.
32. Morel, J. C., C. C. Park, K. Zhu, P. Kumar, J. H. Ruth, and A. E. Koch. 2002. Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. J. Biol. Chem. 277: 34679-34691.
33. Kalina, U., D. Kauschat, N. Koyama, H. Nuernberger, K. Ballas, S. Koschmieder, G. Bug, W. K. Hofmann, D. Hoelzer, and O. G. Ottmann. 2000. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-γ production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J. Immunol. 165: 1307-1313.
34. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15: 675-705.
35. Rollins, B. J. 1997. Chemokines. Blood 90: 909-904.
36. Neumann, D., S. Lienenklaus, O. Rosati, and M. U. Martin. 2002. IL-1β-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1. Eur. J. Immunol. 32: 3689-3698.
37. Gracie, J. A., S. E. Robertson, and I. B. McInnes. 2003. Interleukin-18. J. Leukocyte Biol. 73: 213-224.
38. Kojima, H., Y. Aizawa, Y. Yanai, K. Nagaoka, M. Takeuchi, T. Ohta, H. Ikegami, M. Ikeda, and M. Kurimoto. 1999. An essential role for NF-κB in IL-18-induced IFN-γ expression in KG-1 cells. J. Immunol. 162: 5063-5069.
39. Matsumoto, S., K. Tsuji-Takayama, Y. Aizawa, K. Koide, M. Takeuchi, T. Ohta, and M. Kurimoto. 1997. Interleukin-18 activates NF-κB in murine T helper type 1 cells. Biochem. Biophys. Res. Commun. 234: 454-457.
40. Suzuki, N., N. J. Chen, D. G. Millar, S. Suzuki, T. Horacek, H. Hara, D. Bouchard, K. Nakanishi, J. M. Penninger, P. S. Ohashi, and W. C. Yeh. 2003. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses. J. Immunol. 170: 4031-4035.
41. Lee, J. K., S. H. Kim, E. C. Lewis, T. Azam, L. L. Reznikov, and C. A. Dinarello. 2004. Differences in signaling pathways by IL-1β and IL-18. Proc. Natl. Acad. Sci. USA 101: 8815-8820.
42. Chandrasekar, B., S. Mummidi, W. C. Claycomb, R. Mestril, and M. Nemer. 2005. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J. Biol. Chem. 280: 4553-4567.